Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sangle, S.
Right arrow Articles by D'Cruz, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sangle, S.
Right arrow Articles by D'Cruz, D. P.
Related Collections
Right arrow Vasculitis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2002; 41: 589-590
© 2002 British Society for Rheumatology

Letters to the Editor

Sulphamethoxazole–trimethoprim in the treatment of limited paranasal Wegener's granulomatosis

S. Sangle, M. Y. Karim, G. R. V. Hughes and D. P. D'Cruz

Lupus Research Unit, The Rayne Institute, 4th Floor, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK

SIR, Wegener's granulomatosis (WG) is a systemic vasculitis that affects predominantly the upper and lower respiratory tract, kidneys, joints and skin. It is also recognized in limited form, where it occurs without renal involvement. Both the systemic and the limited form of WG are known to cause severe morbidity and destructive lesions. Treatment modalities for both these forms consist of high doses of steroids and cyclophosphamide. Here we present what we believe to . . . [Full Text of this Article]

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
R. A. DeRemee
Trimethoprim-sulphamethoxazole for the treatment of Wegener's granulomatosis
Rheumatology, February 1, 2003; 42(2): 396 - 396.
[Full Text] [PDF]